API Gallery
The Amylmetacresol market is growing at a steady rate, with a projected CAGR of 6.0% during the forecast period. Amylmetacresol, a primary antibacterial in throat lozenges, is effective in treating sore throats and mild oral infections.
The Anagrelide Hydrochloride market continues to grow, with a projected CAGR of about 5.2% over the forecast period. Anagrelide Hydrochloride is primarily used to treat essential thrombocythemia (ET), a rare blood condition in which the bone marrow overproduces platelets, increasing the risk of blood clots.
The Anamorelin HCl market continues to grow, with a projected CAGR of about 9% over the forecast period.
The Eszopiclone market is projected to grow at a CAGR of 5.1% from 2025 to 2035, driven by a surge in the global prevalence of insomnia and sleep-related disorders.
The global Anamorelin market is predicted to increase at a CAGR of 10% over the forecast period. Anamorelin, a ghrelin receptor agonist, is gaining popularity as a new treatment for cancer cachexia, a severe illness that causes weight loss, muscle atrophy, weariness, and loss of appetite in cancer patients.
The Anastrozole market is expected to expand at a compound annual growth rate (CAGR) of 2.80% from 2021 to 2028. This increase is mostly driven by the rising prevalence of hormone receptor-positive breast cancer, particularly among postmenopausal women.
The Andrographolide market is witnessing significant growth, driven by increasing demand for natural and plant-based medicinal compounds due to their extensive therapeutic properties. The global Andrographolide market is projected to growing at a CAGR of 7.5% during the forecast period.
The Anethole Trithione market is expected to grow at a CAGR of 4.28% throughout the projected period, owing to the rising prevalence of chronic diseases such as liver problems, digestive troubles, and cancer-related complications.
The Angiotensin II market is anticipated to grow at a CAGR of 4.9% during the projected period, owing to the rising prevalence of cardiovascular illnesses, the widespread use of Angiotensin II receptor blockers (ARBs) for hypertension management, and increased awareness of cardiovascular health.
The Anidulafungin market is projected a exhibiting Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period. This growth is primarily driven by the increasing prevalence of invasive fungal infections, such as candidiasis and aspergillosis, particularly among immunocompromised patients, including those undergoing chemotherapy, organ transplants, and individuals with HIV/AIDS.
The Aniracetam market is experiencing a Compound Annual Growth Rate (CAGR) of 10% during the forecast period, driven by increasing awareness of cognitive enhancement supplements, rising stress levels, and the growing demand for nootropics in addressing cognitive and mental health issues.
The Etanercept market is projected to expand at a CAGR of 6.3% from 2025 to 2035, fueled by the rising global incidence of autoimmune disorders and the increasing preference for biologic therapies.
The Etelcalcetide Hydrochloride market is projected to grow at a CAGR of 6.9% from 2025 to 2035, driven by increasing demand for advanced therapies in managing secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) undergoing hemodialysis.
The Nalidixic Acid market is projected to grow at a CAGR of 4.2% between 2025 and 2035, sustained by its continued use in specific bacterial infections and as a foundational quinolone antibiotic in select therapeutic niches.
The Nalmefene Hydrochloride market is expected to grow at a CAGR of 6.4% from 2025 to 2035, driven by rising incidences of alcohol dependence and opioid-related emergencies.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
